GUARDIGLI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 1.720
EU - Europa 484
AS - Asia 453
SA - Sud America 11
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.673
Nazione #
US - Stati Uniti d'America 1.708
CN - Cina 211
SG - Singapore 149
UA - Ucraina 129
IT - Italia 126
DE - Germania 76
TR - Turchia 66
GB - Regno Unito 49
SE - Svezia 30
FI - Finlandia 29
ID - Indonesia 12
FR - Francia 10
CA - Canada 8
DK - Danimarca 7
BE - Belgio 6
VN - Vietnam 6
CO - Colombia 5
IE - Irlanda 4
LT - Lituania 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IN - India 3
CH - Svizzera 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
EG - Egitto 1
IM - Isola di Man 1
JP - Giappone 1
KR - Corea 1
LU - Lussemburgo 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.673
Città #
Woodbridge 209
Chandler 174
Fairfield 167
Jacksonville 149
Houston 123
Singapore 116
Ashburn 109
Ann Arbor 88
Wilmington 74
Seattle 65
Nanjing 51
Cambridge 46
Princeton 44
Izmir 43
Shanghai 30
Boardman 27
San Diego 26
Beijing 25
Ferrara 24
Milan 23
New York 22
Bremen 19
Santa Clara 16
Bologna 13
Shenyang 13
Jakarta 12
Falls Church 11
Jiaxing 8
Nanchang 8
Changsha 7
Dearborn 7
Hebei 7
Naples 7
Acireale 6
Brussels 6
Kunming 6
Odense 6
Redwood City 6
Tianjin 6
Addison 5
Parma 5
San Mateo 5
Jinan 4
London 4
Los Angeles 4
Ningbo 4
Orange 4
Poggio Renatico 4
Toronto 4
Bogotá 3
Dublin 3
Edinburgh 3
Mountain View 3
Munich 3
Rimini 3
Zhengzhou 3
Aversa 2
Brno 2
Brugherio 2
Bucharest 2
Des Moines 2
Forest City 2
Frankfurt am Main 2
Guangzhou 2
Hong Kong 2
Indiana 2
Lappeenranta 2
Leawood 2
Lima 2
Lugano 2
Norwalk 2
Ottawa 2
Piacenza 2
Rome 2
San Salvador 2
Sassari 2
Taizhou 2
Tappahannock 2
Verona 2
Washington 2
Alcobaça 1
Atlanta 1
Auburn Hills 1
Auckland 1
Augusta 1
Bandar Seri Begawan 1
Bethesda 1
Buenos Aires 1
Cairo 1
Celbridge 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Douglas 1
Edmonton 1
Florence 1
Hangzhou 1
Helsinki 1
Heredia 1
Totale 1.931
Nome #
Reperfusion Damage - A Story of Success, Failure, and Hope 128
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 113
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 108
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 104
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 104
The heart rate story 92
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 91
Oxidative stress during myocardial ischaemia and heart failure 91
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 91
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 91
Angiotensin II overproduction: enemy of the vessel wall 88
A modern fairy tale 84
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. 83
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 82
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 79
[Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention] 78
Tirofiban: a critical reappraisal of the clinical use, recent developpements and future perspectives. 72
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 72
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 66
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 65
Bradykinin and coronary artery disease 63
null 61
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 61
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 56
Ferrara VI 55
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 55
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 53
LEFT VENTRICULAR REMODELLING AT THE LIMITS 48
FERRARA: CITTÀ DELLA PREVENZIONE 47
Safety and efficacy of new-generation coronary bioresorbable scaffolds 47
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 42
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 40
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 39
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 39
Ferrara II 37
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 35
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 32
[Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 23
The future of cardiovascular prevention: between fiction and reality 23
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 22
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 20
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 11
MULTIMODALITY IMAGING IN ACROMEGALIC CARDIOMIOPATHY: A CASE REPORT 11
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 9
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 9
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 9
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 8
One-year outcome of elderly patients with endocarditis: a retrospective observational study 8
Totale 2.745
Categoria #
all - tutte 16.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 263
Totale 17.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020258 0 0 0 0 25 50 32 45 29 56 13 8
2020/2021311 30 50 10 38 18 28 3 38 7 35 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/2025268 23 35 87 71 52 0 0 0 0 0 0 0
Totale 2.745